Dr. Anupriya Kumar Email & Phone Number

Cologne, Nrw, De

Cologne, North Rhine-Westphalia, Germany

Managing large pharma, biotechs and start up accounts.

Köln, Nordrhein-Westfalen, Deutschland

Eschborn, Hesse, Germany

• Managing and leading a team of 5 • Plan and organize team objectives and priorities • Develop and execute reporting and business process design• Monitor daily operations and enhance processes to maximize efficiency and minimize risks• Coordinate the work of internal and external teams to develop new products• Partnership management with external stakeholders• Innovation management via customer immersion• Product discovery and MVP development for an AI product

Mannheim, Baden-Württemberg, Germany

• Run full-sales cycle from qualifying leads to in-person or online meetings, value proposition, technical training, pitching, consulting, account planning, forecasting and market analysis. • Managed lead and customer data for follow up sales operations.• Boosted sales for digitalization of research processes in experimental laboratories. • Manage account resources such as scientists, IT and support.

Mannheim Area, Germany

Run pre-sales cycle from researching prospects, to in-person meeting, value proposition, technical training, pitching, consulting, account planning and market analysis.

Nagoya, Aichi, Japan

1. Found novel inhibitors for β-lactamase protein OXA-48 against antibiotic resistance.2. Established both computational and experimental protocols to facilitate quick modelgeneration and efficient experimental verification in assays.

Nagoya, Aichi, Japan

1. Designed novel inhibitors for Thyroid Hormone Receptor using 3D-QSAR, docking and bioisostere replacement2. Established virtual screening protocol using 3D-QSAR model for circadian rhythm modulators

Bangalore

1. Designed virtual screening protocol to select 10,000 compounds for InhA from 3.2 million AstraZeneca compound collection which led to 3 new series of compounds. 2. Analyzed fragment based screening data and led medicinal chemistry design for 3 series of compounds for target InhA.

1. Library design for whole cell screening 1.1 Generation of ligand based and target based virtual library for Whole cell based screening. 1.2 Evaluation of protein active site HOTSPOTS (Superstar, Triphic) for target based library design. 1.3 Similarity and diversity search (Rocs, Basic knowledge of Daylight) of small molecules/ligands. 1.4 Conformation generation and analysis (Corina, Moe, Omega) of small molecules/ligands.2. Structure-based and ligand-based drug design to build Structure activity relationship for hit leads 2.1 Multiple template-based homology modeling. (Maestro, Swissmodel) 2.2 Docking into the modeled structure for database screening (FRED, Glide, GOLD). 2.3 Design of new ligand derivatives based on quantum chemical calculations by analyzing molecular orbitals and electron density maps (Gaussian 03/09) for improving the potency and solubility.3. Binding mode and binding free energy of ligands 3.1 Molecular dynamics simulation (Gaussian 03/09, Amber 9, VMD) of protein-ligand systems.MMPBSA/GBSA (Amber 9) for prediction of binding affinity and ligand-based drug design.4. Protocol for Target selection 4.1 Evaluation of a target based on druggability (Sitemap), hydrophobic/hydrophilic surface area, network pathway analysis, redundancy, human homologues and essentiality data. 5. Theoretical models for genotoxicity prediction 5.1 Redox potential calculation by using quantum mechanics (Gaussian 03/09) for mutagenic compounds and suggest the functional groups for reducing genotoxicity.

Project on water mediated enzyme catalysis by using classical molecular dynamics simulations and quantum chemistry calculations.

1. Study of solvation phenomena of various inorganic as well as organic compounds by using ab initio quantum mechanics calculations.2. Time evolution of geometrical parameters and charge transfer processes were studied for pyrrole-water and water cluster systems by using ab initio molecular dynamics simulations. 3. Extensive study of hydrogen bonding and π-π interactions for various small organic molecule dimers. 4. For studying the voltage gated HERG channel, the three-dimensional structures were modelled by homology modelling and molecular dynamics simulation was performed. 5. For protein-protein interactions, the binding of Amyloid β-peptide to Acetylecholinesterase was studied by using bioinformatics tools and molecular dynamics simulations.

Electronic structure calculations to study hydration phenomena

Structure-activity relationship (SAR including 3D-QSAR) analysis of some generated pharmacophores/3D-QSAR of Calcium Channel Blockers with an attempt to build a database for them.

Master'S Degree, Chemistry

Activities and Societies: Coordinator for Chemistry Department in Science Fair 2002 in BITS, Pilani, India. Computer Aided Drug Design.

Zertifikat Deutsch B1, German Language

Ph. D., Computational Physical Chemistry

Activities and Societies: Dance and Badminton club member Dissertation titled “Molecular dynamics simulations of excited state clusters.

High School

Numerous Awards in Painting Competitions. United Nations General Knowledge certificate.

Education record

Doctor Of Philosophy - Phd

Education record

Doctor Of Philosophy - Phd, Computational Science

Education record